cs.LGNov 18, 2026

Prognosis Without Prediction: The Intrinsic Geometry of Survival

Authors: Atahan Karagoz

Organizations: Department of Computer Science, University of Basel, Basel, Switzerland

Abstract

Modeling systemic failure in high-dimensional environments is fundamentally limited by supervised algorithms that attempt to predict sparse, noisy or censored endpoints. To break this reliance on explicit outcome regression, we engineered the Self-Organizing Survival Manifolds (SOSM) framework, a deep learning architecture that decouples unsupervised representation learning from survival labels and treats time-to-event progression as an emergent geometric property. The system projects heterogeneous multi-omics arrays into a unified latent space governed by a pseudotime-weighted, curvature-minimizing graph Laplacian, organizing patient trajectories along low-dissipation geodesic flows. To validate the framework, we applied this architecture to a 184-patient clear cell renal cell carcinoma multi-omics cohort. Across a deterministic 5-fold cross-validation pipeline, SOSM achieved a mean Concordance Index of 0.768±0.0680.768 \pm 0.068, while out-of-fold risk stratification yielded significant survival divergence (log-rank p<0.001p < 0.001) accompanied by a 14.7% increase in local manifold dissipation among high-risk patients. Furthermore, interrogating the network's encoder weights confirmed that the model autonomously recovered canonical metabolic and microenvironmental drivers of disease progression without supervised feature selection. By demonstrating that systemic failure can be mapped as a geometric phase transition, SOSM establishes a generalizable computational engine for prognostic modeling across biological, industrial and financial complex systems.

Figures & tables

Explore similar work

Oct 30, 2026

TopoHyperClinicalGraph: A Geometry and Topology-Aware Multimodal Framework for Cancer Survival Prediction

We developed TopoHyperClinicalGraph, a multimodal framework combining hyperbolic tissue geometry, persistent topology and clinical graph learning for cancer survival prediction. Pre-extracted UNI2-h features are reduced from 1,536 to 1,024 dimensions using training-fold PCA. A pathology backbone combines hyperbolic neighborhoods with Lorentz-centroid attention pooling. Once frozen, its survival logits are adjusted using persistence descriptors from up to 64 landmarks per slide and sampling controls. A five-node clinical graph then learns a further correction from age, sex, stage, T and N. Five-fold patient-level evaluation covered eight TCGA and CPTAC cohorts with 2,364 patients. Mean validation-selected C-indices for TopoHyperClinicalGraph versus pathology-only spatial PatchGCN were 0.7563 versus 0.7386 in COADREAD, 0.6220 versus 0.5998 in HNSC, 0.6755 versus 0.6535 in BRCA and 0.6409 versus 0.6176 in STAD. CPTAC scores were 0.5984 in HNSC, 0.6060 in PDA, 0.8055 in CCRCC and 0.7192 in LUAD. CPTAC-HNSC used TCGA-initialized adaptation; other CPTAC backbones were trained within their cohorts. Geometry accounted for most pathology-only gains, with smaller persistence effects. Clinical graph fusion exceeded its matched node-wise control in five cohorts, tied in one and scored lower in two; clinical-only prediction exceeded fusion in three CPTAC cohorts. The framework supports separate evaluation of geometric, topological and clinical contributions. All scores were validation-selected; independent testing is needed to establish generalizability.
Apr 27, 2026

PathMoG: A Pathway-Centric Modular Graph Neural Network for Multi-Omics Survival Prediction

Cancer survival prediction from multi-omics data remains challenging because prognostic signals are high-dimensional, heterogeneous, and distributed across interacting genes and pathways. We propose PathMoG, a pathway-centric modular graph neural network for multi-omics survival prediction. PathMoG reorganizes genome-scale inputs into 354 KEGG-informed pathway modules, introduces a Hierarchical Omics Modulation module to condition gene-expression representations on mutation, copy number variation, pathway, and clinical context, and uses dual-level attention to capture both intra-pathway driver signals and inter-pathway clinical relevance. We evaluated PathMoG on 5,650 patients across 10 TCGA cancer types and observed consistent improvements over representative survival baselines. The framework further provides gene-level, pathway-level, and patient-level interpretability, supporting biologically grounded and clinically relevant risk stratification.
Sep 18, 2026

MIST: Multimodal Survival Prediction with Genomic-Guided Histology Attention

Multimodal survival models can combine complementary prognostic information from whole-slide images and genomic profiles, but effective fusion remains challenging amid external cohort shift and computational complexity. To address these challenges, we propose MIST, multimodal survival prediction with genomic-guided histology attention. MIST represents genomic features as tokens and allows them to query compact foundation-model-derived histology context tokens before survival prediction. This design enriches molecular information with histology context rather than merging separately encoded modalities only at the final stage. Training combines discrete-time survival prediction with genomic feature masking, WSI dropout, and paired WSI-genomics contrastive alignment. Across four external evaluations in colon, renal, lung, and glioblastoma cohorts, MIST improves external C-index over standard fusion baselines in the primary comparisons. These results support genomic-guided histology attention as a compact and effective strategy for multimodal oncology outcome prediction. Our code is available at https://github.com/samiyavuuz/MIST .